Understanding Nurtec ODT: Key Information for Migraine Patients
Nurtec ODT is FDA-approved for both acute treatment and prevention of migraine in adults
Nurtec ODT (rimegepant) is an FDA-approved prescription medication for both acute treatment and preventive treatment of migraine in adults. As an orally disintegrating tablet, it dissolves on the tongue without water, making it convenient for patients experiencing nausea during migraine attacks. The medication belongs to a class called CGRP receptor antagonists, which work by blocking a protein involved in migraine pain pathways.
For acute treatment, Nurtec ODT can be taken as needed when a migraine occurs, with a maximum of one dose per day. When used for prevention, it is typically taken every other day. Patients should discuss with their healthcare provider which treatment approach is most appropriate for their specific migraine pattern and medical history.
Common side effects may include nausea and stomach pain or indigestion. Patients should inform their healthcare provider about all medications they are taking, as Nurtec ODT may interact with certain drugs. The medication is not recommended for patients with severe liver or kidney problems.
Before starting Nurtec ODT, patients should have a thorough discussion with their healthcare provider about their migraine history, current medications, and treatment goals. This helps ensure the medication is appropriate and used safely as part of a comprehensive migraine management plan.